HALO logo
halo search icon
BioNTech SE Sponsored ADR

US$90.36

Price Change Indicator
2.57 (2.93%)
BioNTech SE Sponsored ADR
BNTX · NAS

BioNTech SE Sponsored ADR

Start Trading BNTX for Free

US$90.36

Price Arrow2.57 (2.93%)
20/05/2026 04:00:00 PM
All-Consensus
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BioNTech SE Sponsored ADR Overview

BNTX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BNTX

icon
icon

Telephone

49.6131.9084.0

icon

Address

An der Goldgrube 12, Mainz, Rheinland-Pfalz 55131

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BNTX Price Chart

Key Stats

Market Cap

US$22.20B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 79.52 - 124

Trade Value (12mth)

US$25,429,709.00

1 week

-1.97%

1 month

-21.34%

YTD

-9.2%

1 year

-11.4%

All time high

464.00

Key Fundamentals

EPS 3 yr Growth

-112.20%

EBITDA Margin

-9.30%

Operating Cashflow

€456m

Free Cash Flow Return

2.40%

ROIC

-5.90%

Interest Coverage

-18.80

Quick Ratio

7.50

Other Data

Shares Outstanding (Fully Diluted)

253m

HALO Sector

Healthcare

Next Company Report Date

30-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

BNTX Announcements

Latest Announcements

DateAnnouncements
16 May 26
07 May 26
05 May 26
05 May 26
13 April 26

BNTX Fundamentals

Per Share Records

Historical data

Forecast data

EUR2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 €locklocklocklock3.86-2.77-4.7locklocklock
EPS (Fully Diluted)
 €locklocklocklock3.83-2.77-4.7locklocklock
Growth
 %locklocklocklock-90-171.7-69.8locklocklock
PE
 Xlocklocklocklock25.2N/AN/Alocklocklock
EV/EBITDA
 Xlocklocklocklock11N/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of BioNTech SE Sponsored ADR (BNTX:NAS)?
Halo FAQ
The current share price of BioNTech SE Sponsored ADR (BNTX:NAS) is USD$90.36.
What is the 52-week high share price for BioNTech SE Sponsored ADR (BNTX:NAS)?
Halo FAQ
The 52-week high share price for BioNTech SE Sponsored ADR (BNTX:NAS) is USD$124.00.
What is the 52-week low share price for BioNTech SE Sponsored ADR (BNTX:NAS)?
Halo FAQ
The 52-week low share price for BioNTech SE Sponsored ADR (BNTX:NAS) is USD$79.52.
What is the dividend yield for BioNTech SE Sponsored ADR (BNTX:NAS)?
Halo FAQ
BioNTech SE Sponsored ADR (BNTX:NAS) does not pay a dividend.
What was BioNTech SE Sponsored ADR (BNTX:NAS) last dividend payment?
Halo FAQ
The last dividend payment of BioNTech SE Sponsored ADR (BNTX:NAS) is USD$1.55.
What is the franking level for BioNTech SE Sponsored ADR (BNTX:NAS)?
Halo FAQ
BioNTech SE Sponsored ADR (BNTX:NAS) has a franking level of 0.00%.
In which sector is BioNTech SE Sponsored ADR (BNTX:NAS) classified?
Halo FAQ
BioNTech SE Sponsored ADR (BNTX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial